Why Manitowoc, Endocyte, and Seattle Genetics Tumbled Today

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 2 May, 2014 by The TZ Newswire Staff

Why Manitowoc, Endocyte, and Seattle Genetics Tumbled Today

Stocks generally disappointed investors on Friday as the Ukrainian situation trumped strong jobs data, but these three stocks performed much worse than the broader market. Find out why.

See also
- Next Article U.S. jury orders smartphone maker Samsung to pay Apple $120 million
- Previous Article Marc Faber Warns "Social Media Stocks Are Just The Start, Market Crash Coming In 2nd Half"
Editorial Calender

May 2014

M T W T F S S

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30 31

« Jun Jun »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 2 May, 2014 by The TZ Newswire Staff

Why Manitowoc, Endocyte, and Seattle Genetics Tumbled Today

See also

Editorial Calender

Recent Tags